Mechanism of the lack of a beneficial response to inotropic drugs in hemorrhagic shock.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D002403:Cathepsins / Q000097:blood; D004285:Dogs; D005934:Glucagon / Q000009:adverse effects*; D005966:Glucuronidase / Q000097:blood; D007545:Isoproterenol / Q000009:adverse effects*; D007799:Lanatosides / Q000009:adverse effects*; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology; D012039:Regional Blood Flow / Q000187:drug effects; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D013154:Spleen / Q000098:blood supply / Q000187:drug effects / Q000473:pathology; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D007799:Lanatosides; D005934:Glucagon; D005966:Glucuronidase; D002403:Cathepsins; D007545:Isoproterenol